Who backs ProLynx?
5 investors| Investor | Type |
|---|---|
| US National Science Foundation | Other |
| OrbiMed | Growth equity |
| 5AM Ventures | PE / buyout |
| Monograph Capital | — |
| National Institute of Diabetes and Digestive and Kidney Diseases | — |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for ProLynx
- ·The full record, as it builds
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 5 firms already write checks for companies like ProLynx. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.